{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:36:15Z","timestamp":1792571775311,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1990,5,1]],"date-time":"1990-05-01T00:00:00Z","timestamp":641520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[1990,5]]},"DOI":"10.1007\/bf00403322","type":"journal-article","created":{"date-parts":[[2004,10,23]],"date-time":"2004-10-23T23:15:01Z","timestamp":1098573301000},"page":"285-289","source":"Crossref","is-referenced-by-count":100,"title":["Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians"],"prefix":"10.1007","volume":"33","author":[{"given":"A.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Nezzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Uren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. C.","family":"Knowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. H.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. C.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.5.5.527","volume":"5","author":"E Opie","year":"1901","unstructured":"Opie E (1901) The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islets of Langerhans. J Exp Med 5: 527?540","journal-title":"J Exp Med"},{"key":"CR2","first-page":"151","volume":"9","author":"A Clark","year":"1988","unstructured":"Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJS, Holman RR, Turner RC (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in Type 2 diabetes. Diabetes Res 9: 151?160","journal-title":"Diabetes Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1055\/s-2008-1070828","volume":"105","author":"HM Schneider","year":"1980","unstructured":"Schneider HM, Storkel S, Will W (1980) Das Amyloid der Langerhansschen Inseln und seine Beziehung zum Diabetes Mellitus. Dtsch Med Wochenschr 105: 1143?1147","journal-title":"Dtsch Med Wochenschr"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/BF00274799","volume":"30","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wilander E, Westermark GT, Johnson KH (1987) Islet amyloid polypeptide-like immunoreactivity in the islet B cells of Type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia 30: 887?892","journal-title":"Diabetologia"},{"key":"CR5","first-page":"807","volume":"26","author":"KA Vishwanathan","year":"1972","unstructured":"Vishwanathan KA, Bazaz-Malik G, Dandekar J, Vaishnava (1972) A qualitative and quantitative histological study of the islets of Langerhans in diabetes mellitus. Indian J Med Sci 26: 807?812","journal-title":"Indian J Med Sci"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1620\/tjem.125.185","volume":"125","author":"K Saito","year":"1978","unstructured":"Saito K, Takahashi T, Yaginuma N, Iwama N (1978) Islet morphometry in the diabetic pancreas of man. Tohoku J Exp Med 125: 185?197","journal-title":"Tohoku J Exp Med"},{"key":"CR7","first-page":"801","volume":"35","author":"ET Bell","year":"1959","unstructured":"Bell ET (1959) Hyalinization of the islets of Langerhans in non-diabetic individuals. Am J Pathol 35: 801?805","journal-title":"Am J Pathol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0046-8177(81)80197-9","volume":"12","author":"AL Maloy","year":"1981","unstructured":"Maloy AL, Longnecker DS, Greenberg ER (1981) The relation of islet amyloid to the clinical type of diabetes. Human Pathol 12: 917?922","journal-title":"Human Pathol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(87)90825-7","volume":"II","author":"A Clark","year":"1987","unstructured":"Clark A, Cooper GJS, Lewis CE, Morris JF, Willis AC, Reid KBM, Turner RC (1987) Islet amyloid formed from diabetes associated peptide may be pathogenic in type 2 diabetes. Lancet II: 231?234","journal-title":"Lancet"},{"key":"CR10","unstructured":"Anonymous (1987) Pancreatic abnormalities in type 2 diabetes mellitus. Editorial, Lancet II: 1497?1498"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00452067","volume":"29","author":"CF Howard","year":"1986","unstructured":"Howard CF (1986) Longitudinal studies on the development of diabetes in individual macaca nigra. Diabetologia 29: 301?306","journal-title":"Diabetologia"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","volume":"84","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci 84: 3881?3885","journal-title":"Proc Natl Acad Sci"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJS Cooper","year":"1987","unstructured":"Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM (1987) Purification and characterisation of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Nat Acad Sci 84: 8628?8632","journal-title":"Proc Nat Acad Sci"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0006-291X(86)90708-4","volume":"140","author":"P Westermark","year":"1986","unstructured":"Westermark P, Wernstedt C, Wilander E, Sletten K (1986) A novel peptide in the calcitonin gene-related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140: 826?831","journal-title":"Biochem Biophys Res Commun"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1073\/pnas.85.20.7763","volume":"85","author":"GJS Cooper","year":"1988","unstructured":"Cooper GJS, Leighton B, Dimitriadis GD, Parry-Billings M, Kowalchuk JM, Howland K, Rothbard JB, Willis AC, Reid KBM (1988) Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci 85: 7763?7766","journal-title":"Proc Natl Acad Sci"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-5793(89)81467-X","volume":"251","author":"C Betscholz","year":"1989","unstructured":"Betscholz C, Christmansson L, Engstrom U, Rosman F, Svensson V, Johnson KH, Westermark P (1989) Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains the differences in islet amyloid formation between species. FEBS Let 251: 261?264","journal-title":"FEBS Let"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1073\/pnas.86.15.5738","volume":"86","author":"M Nishi","year":"1989","unstructured":"Nishi M, Chan SS, Naganatsu S, Bell GI, Steiner DF (1989) Conservation of the sequence of islet amyloid polypeptide in 5 mammals is consistent with its putative role as an islet hormone. Proc Natl Acad Sci USA 86: 5738?5742","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR18","first-page":"414","volume":"127","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH (1987) Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 127: 414?417","journal-title":"Am J Pathol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/oxfordjournals.aje.a112648","volume":"108","author":"WC Knowler","year":"1978","unstructured":"Knowler WC, Bennett PH, Hamman RF, Miller M (1978) Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108: 497?505","journal-title":"Am J Epidemiol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a113079","volume":"113","author":"WC Knowler","year":"1981","unstructured":"Knowler WC, Pettitt DJ, Savage PJ, Bennett PH (1981) Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol 113: 144?156","journal-title":"Am J Epidemiol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajpa.1330620114","volume":"61","author":"WC Knowler","year":"1983","unstructured":"Knowler WC, Pettitt DJ, Bennett PH, Williams RC (1983) Diabetes mellitus in the Pima Indians: genetic and evolutionary considerations. Am J Phys Anthrop 61: 107?114","journal-title":"Am J Phys Anthrop"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2337\/diab.24.4.362","volume":"24","author":"PJ Savage","year":"1975","unstructured":"Savage PJ, Dippe SE, Bennett PH et al. (1975) Hyperinsulinemia and hypoinsulinemia. Insulin response to oral carbohydrate over a wide spectrum of glucose tolerance. Diabetes 24: 362?368","journal-title":"Diabetes"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1210\/jcem-51-4-739","volume":"51","author":"M Nagulesparan","year":"1980","unstructured":"Nagulesparan M, Savage PJ, Mott DM, Johnson GC, Unger RH, Bennett PH (1980) Increased insulin resistance in obese, glucose intolerance southwestern American Indians: evidence for a defect not explained by obesity. J Clin Endocrinol Metab 51: 739?743","journal-title":"J Clin Endocrinol Metab"},{"key":"CR24","first-page":"47","volume":"36","author":"C Bogardus","year":"1987","unstructured":"Bogardus C, Lillioja S, Foley J, Christin L, Freymond D, Nyomba B, Bennett PH, Reaven G, Salans L (1987) Insulin resistance predicts the development of non-insulin-dependent diabetes mellitus in Pima Indians. Diabetes 36: 47 (A)","journal-title":"Diabetes"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM198805123181901","volume":"318","author":"S Lillioja","year":"1988","unstructured":"Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C (1988) Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318: 1217?1225","journal-title":"N Engl J Med"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/dmr.5610040508","volume":"4","author":"S Lillioja","year":"1988","unstructured":"Lillioja S, Bogardus C (1988) Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev 4: 517?540","journal-title":"Diabetes Metab Rev"},{"key":"CR27","first-page":"9","volume":"7272","author":"Report of a WHO Study Group","year":"1985","unstructured":"Report of a WHO Study Group (1985) Diabetes mellitus. WHO Tech Rep Ser 7272: 9?17","journal-title":"WHO Tech Rep Ser"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1083\/jcb.33.2.307","volume":"33","author":"PK Nakane","year":"1967","unstructured":"Nakane PK, Pierce GB (1967) Enzyme labelled antibodies for the light and electron microscopic localisation of tissue antigens. J Cell Biol 33: 307?318","journal-title":"J Cell Biol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diab.28.10.937","volume":"28","author":"PJ Savage","year":"1979","unstructured":"Savage PJ, Bennett PH, Senter RG, Miller M (1979) High prevalence of diabetes in young Pima Indians. Diabetes 28: 937?942","journal-title":"Diabetes"},{"key":"CR30","first-page":"161","volume":"17","author":"HL Katzeff","year":"1985","unstructured":"Katzeff HL, Savage PJ, Barclay-White B, Nagulesparan M, Bennett PH (1985) C-peptide measurements in the differentiation of Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 17: 161?164","journal-title":"Diabetologia"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF00290389","volume":"27","author":"A Clark","year":"1984","unstructured":"Clark A, Holman RR, Matthews DR, Hockaday TDR, Turner RC (1984) Non-uniform distribution of islet amyloid in the pancreas of ?maturity-onset? diabetic patients. Diabetologia 27: 527?528","journal-title":"Diabetologia"},{"key":"CR32","first-page":"1","volume":"130","author":"KH Johnson","year":"1988","unstructured":"Johnson KH, O'Brien TD, Hayden DW, Ghobrial HKG, Westermark P (1988) Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase antiperoxidase (PAP) and protein A gold techniques. Am J Pathol 130: 1?8","journal-title":"Am J Pathol"},{"key":"CR33","first-page":"179","volume":"257","author":"A Clark","year":"1988","unstructured":"Clark A, Edwards CA, Ostle LR, Sutton R, Rothbard JB, Morris JF, Turner RC (1988) Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects. Cell Tiss Res 257: 179?185","journal-title":"Cell Tiss Res"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-5793(88)80922-0","volume":"239","author":"S Mosselman","year":"1988","unstructured":"Mosselman S, Hoppener JWM, Zandberg J, van Mansfield ADM, Geurts van Kessel AHM, Lips CJM, Jansz HS (1988) Islet amyloid polypeptide (IAPP): identification and chromosomal localization of the human gene. Febs Lett 239: 227?232","journal-title":"Febs Lett"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"17243","DOI":"10.1016\/S0021-9258(19)77825-9","volume":"263","author":"T Sanke","year":"1988","unstructured":"Sanke T, Bell GI, Sample C, Rubenstein AH, Steiner DF (1988) An islet amyloid peptide is derived from an 89 amino acid precursor by proteolytic processing. J Biol Chem 263: 17243?17246","journal-title":"J Biol Chem"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(87)93008-X","volume":"II","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wilander E, Johnson KH (1987) Islet amyloid polypeptide. Lancet II: 623","journal-title":"Lancet"},{"key":"CR37","first-page":"524A","volume":"32","author":"H Ohsawa","year":"1989","unstructured":"Ohsawa H, Kanatsuku A, Yamaguchi T, Makino H, Yoshida S (1989) Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets Diabetologia 32: 524A","journal-title":"Diabetologia"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/BF01236309","volume":"13","author":"RC Turner","year":"1977","unstructured":"Turner RC, Heding LG (1977) Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas. Diabetologia 13: 571?577","journal-title":"Diabetologia"},{"key":"CR39","first-page":"51","volume":"4","author":"A Clark","year":"1987","unstructured":"Clark A, Matthews DR, Naylor BA, Wells CA, Hosker JP, Turner RC (1987) Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes. Diabetes Res 4: 51?55","journal-title":"Diabetes Res"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM198805123181902","volume":"318","author":"S O'Rahilly","year":"1988","unstructured":"O'Rahilly S, Turner RC, Matthews DR (1988) Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318: 1225?1230","journal-title":"N Engl J Med"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2265.1987.tb03644.x","volume":"26","author":"RC Turner","year":"1987","unstructured":"Turner RC, Rudenski AS, Holman RR, Matthews DR, O'Rahilly SP (1987) Quantitative modelling of endocrine diseases. Clin Endocrinol 26: 107?116","journal-title":"Clin Endocrinol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00403322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00403322\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00403322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T17:29:34Z","timestamp":1682789374000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00403322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,5]]}},"alternative-id":["BF00403322"],"URL":"https:\/\/doi.org\/10.1007\/bf00403322","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,5]]}}}